Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, providing promising progress throughout different health-related and industrial applications. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, extra dependable alternative for therapeutic use,